Literature DB >> 15524057

The potential role of statins in contrast nephropathy.

N Attallah1, L Yassine, J Musial, J Yee, K Fisher.   

Abstract

BACKGROUND: Administration of contrast agents may result in an acute reduction in renal function and occasionally end-stage renal disease. Risk factors for contrast-induced nephropathy (CN) are preexisting renal dysfunction, diabetes and reduced effective arterial volume. Hydration and use of nonionic contrast agents have been reported to ameliorate CN. Reactive oxygen species may have a role in the pathogenesis of CN. Statins decrease free oxygen radicals in animals. We retrospectively tested the hypothesis that administering statins prior to cardiac catheterization decreases the incidence of CN.
METHODS: A total of 1,002 patients were studied. Patients with a stable baseline serum creatinine (SCr) > or = 1.5 mg/dl who had cardiac catheterization between July 1997 and June 2002, were included in the study. None of the patients were taking statins before admission. 250 patients were started on a statin before the procedure and 752 patients were not. The SCr was followed for 7 days after the procedure looking for an acute decrement in renal function, dialysis requirement and survival.
RESULTS: The baseline characteristics, SCr, GFR, amount of intravenous fluids and contrast were similar in both groups. The post cath SCr (2.26 vs 3.1 mg/dl, p = 0.001) was significantly better in the statin group. Length of stay (2.72 vs 3.32 days, p = 0.01) and number of patients with acute renal failure (43 (17.2%) vs 168 (22.3%) patients, p = 0.028) were significantly lower in the statin group. Dialysis requirement within 7 days and 28-day survival were similar in both groups.
CONCLUSION: Prophylactic administration of statins along with hydration may be associated with less CN induced by a nonionic, low-osmolality contrast.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15524057     DOI: 10.5414/cnp62273

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  21 in total

1.  Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction.

Authors:  Bing Qiao; Jie Deng; Yi Li; Xiaozeng Wang; Yaling Han
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

3.  Statin treatment before percutaneous cononary intervention.

Authors:  Mario Leoncini; Anna Toso; Mauro Maioli; Francesco Tropeano; Francesco Bellandi
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

4.  Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.

Authors:  Yao-Min Hung; Shoa-Lin Lin; Shih-Yuan Hung; Wei-Chun Huang; Paul Yung-Pou Wang
Journal:  World J Cardiol       Date:  2012-05-26

Review 5.  Contrast-induced nephropathy: pathogenesis and prevention.

Authors:  Robert E Cronin
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

Review 6.  Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Authors:  Amandeep Bajwa; Gilbert R Kinsey; Mark D Okusa
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

Review 7.  [Contrast induced nephropathy].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.

Authors:  Lucia Barbieri; Monica Verdoia; Alon Schaffer; Matteo Nardin; Paolo Marino; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

9.  Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.

Authors:  S Bhandari; A Seth; K K Sethi; S Tyagi; R Gupta; S C Tiwari; S Mehrotra; Ashok Seth; Santanu Guha; P K Deb; Arup Dasbiswas; P P Mohanan; K Venugopal; Nakul Sinha; Brian Pinto; Amal Banerjee; G Sengottuvelu; Roxana Mehran; Peter Mc Collough
Journal:  Indian Heart J       Date:  2012-11-17

10.  Contrast induced nephropathy in urology.

Authors:  Viji Samuel Thomson; Kumar Narayanan; J Chandra Singh
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.